UNICA IRIS Institutional Research Information System

MACCIO', ANTONIO PIETRO MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 127.737
NA - Nord America 12.410
AS - Asia 5.656
SA - Sud America 915
AF - Africa 156
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 6
AN - Antartide 2
Totale 146.893
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 124.324
US - Stati Uniti d'America 12.234
SG - Singapore 2.104
CN - Cina 1.959
UA - Ucraina 915
SE - Svezia 729
BR - Brasile 679
VN - Vietnam 553
DE - Germania 449
FI - Finlandia 372
GB - Regno Unito 324
FR - Francia 290
HK - Hong Kong 256
IN - India 171
KR - Corea 159
CA - Canada 93
AR - Argentina 92
BD - Bangladesh 62
RU - Federazione Russa 59
NL - Olanda 57
ID - Indonesia 51
MX - Messico 43
PK - Pakistan 39
TR - Turchia 39
ZA - Sudafrica 39
EC - Ecuador 38
IQ - Iraq 38
JP - Giappone 36
AT - Austria 33
PH - Filippine 31
PL - Polonia 31
CO - Colombia 30
IE - Irlanda 29
MA - Marocco 28
ES - Italia 25
UZ - Uzbekistan 22
SA - Arabia Saudita 21
EG - Egitto 19
VE - Venezuela 18
CL - Cile 17
IR - Iran 17
KE - Kenya 15
BE - Belgio 14
PE - Perù 14
TN - Tunisia 14
TH - Thailandia 13
CH - Svizzera 10
MY - Malesia 10
RO - Romania 10
UY - Uruguay 10
DZ - Algeria 9
EU - Europa 9
LT - Lituania 9
PY - Paraguay 9
JO - Giordania 8
KZ - Kazakistan 8
AL - Albania 7
CZ - Repubblica Ceca 7
DK - Danimarca 7
NP - Nepal 7
TT - Trinidad e Tobago 7
AZ - Azerbaigian 6
BG - Bulgaria 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
AU - Australia 5
CR - Costa Rica 5
HU - Ungheria 5
LB - Libano 5
LK - Sri Lanka 5
OM - Oman 5
PS - Palestinian Territory 5
AE - Emirati Arabi Uniti 4
EE - Estonia 4
KW - Kuwait 4
PT - Portogallo 4
BZ - Belize 3
CI - Costa d'Avorio 3
ET - Etiopia 3
GR - Grecia 3
MU - Mauritius 3
RS - Serbia 3
AO - Angola 2
AQ - Antartide 2
BB - Barbados 2
BH - Bahrain 2
BW - Botswana 2
BY - Bielorussia 2
CM - Camerun 2
GH - Ghana 2
GT - Guatemala 2
HR - Croazia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MG - Madagascar 2
MN - Mongolia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
Totale 146.855
Salva come PNG Salva come JPEG
Città #
Cagliari 120.333
Uta 3.362
Fairfield 1.281
Woodbridge 1.096
Singapore 1.061
Ashburn 1.019
Houston 760
Dallas 683
Chandler 624
Boardman 594
Nyköping 543
Seattle 535
Ann Arbor 534
Jacksonville 518
Wilmington 504
San Jose 481
Cambridge 420
Beijing 338
Hong Kong 233
Helsinki 227
Dearborn 224
New York 221
Los Angeles 209
Ho Chi Minh City 180
Hefei 177
Lauterbourg 168
Nanjing 167
Boston 159
Santa Clara 147
Seoul 136
The Dalles 123
Council Bluffs 119
Hanoi 114
Buffalo 104
Guangzhou 91
San Diego 88
Shanghai 84
Dong Ket 68
Milan 65
London 60
Menlo Park 57
Shenyang 53
São Paulo 50
Changsha 43
Redwood City 43
Nanchang 42
Redondo Beach 42
Tianjin 42
Toronto 41
Frankfurt am Main 40
Rome 37
Nuremberg 36
Chicago 33
Jinan 33
Orem 33
Hebei 32
Jiaxing 32
Chennai 31
Pune 30
Tokyo 30
Norwalk 28
Atlanta 27
Verona 27
Phoenix 25
Rio de Janeiro 24
Warsaw 23
Mountain View 22
Munich 22
Orange 22
Zhengzhou 21
Haiphong 20
Baghdad 19
Hangzhou 19
Johannesburg 19
Vienna 19
Montreal 18
Amsterdam 17
Da Nang 17
San Francisco 17
Tashkent 17
Auburn Hills 16
Belo Horizonte 14
Denver 14
Nairobi 14
Brooklyn 13
Brussels 13
Buenos Aires 13
Manchester 13
Mumbai 13
Quito 13
Sassari 13
Wuhan 13
Ankara 12
Columbus 12
Ningbo 12
Dhaka 11
Dublin 11
Guayaquil 11
Kunming 11
Thái Nguyên 11
Totale 139.306
Salva come PNG Salva come JPEG
Nome #
Krill Oil supplementation modifies endocannabinoid congeners profile in cachectic advanced cancer patients 3.331
Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach 2.506
Feasibility and safety of total laparoscopic hysterectomy for huge uteri without the use of uterine manipulator: description of emblematic cases 2.460
Randomized phase III clinical trial of a combined treatment with carnitine plus celecoxib +/- megestrol acetate for patients with cancer-related anorexia/cachexia syndrome 2.427
Abdominal leiomyosarcomatosis after surgery with external morcellation for occult smooth muscle tumors of uncertain malignant potential: A case report 2.260
The cachexia score (CASCO) as a tool for staging cachectic cancer patients 2.195
Selenium is effective in inducing lymphocyte progression through cell cycle in cancer patients: potential mechanisms for its activity 2.188
Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches 2.058
Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: Key role of interleukin-6 2.041
A PET-positive rapidly growing mass of the abdominal wall after cesarean section with an unexpected diagnosis of vernix caseosa granuloma: a case report 1.949
Advances in pharmacologic strategies for cancer cachexia 1.898
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia 1.871
Combined laparoscopic excisional surgery for synchronous endometrial and rectal adenocarcinoma in an obese woman 1.854
Laparoscopic removal of a very large uterus weighting 5320 g is feasible and safe: a case report. 1.804
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia 1.787
Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer 1.784
Krill oil to improve blood lipids status in advanced cancer patient with cachexia 1.774
The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study 1.730
Efficacy and safety of a two drug-combination regimen for cancer-related cachexia in the clinical practice. 1.728
Long-Term Survival in a Patient With Abdominal Sarcomatosis From Uterine Leiomyosarcoma: Role of Repeated Laparoscopic Surgery in Treatment and Follow-Up 1.724
Successful laparoscopic management of a giant ovarian cyst 1.722
Future prospects for PD-1 targeting, macrophage infiltration, and IDO pathway activation in patients with sarcomas 1.714
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia 1.713
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results 1.702
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy 1.685
A multitargeted treatment approach for anemia and cachexia in metastatic castration-resistant prostate cancer 1.663
Surprising results of a supportive integrated therapy in myelofibrosis 1.604
Defibrotide in the COVID-19 coagulopathy: what is the timing? 1.578
Large twisted ovarian fibroma associated with Meigs' syndrome, abdominal pain and severe anemia treated by laparoscopic surgery 1.574
Surgical outcome and complications of total laparoscopic hysterectomy for very large myomatous uteri in relation to uterine weight: a prospective study in a continuous series of 461 procedures 1.568
Laparoscopic hysterectomy as optimal approach for 5400 grams uterus with associated polycythemia: A case report 1.544
L-Carnitine: An adequate supplement for a multi-targeted anti-wasting therapy in cancer 1.520
Multifactorial pathogenesis of COVID-19-related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders? 1.483
An interdisciplinary approach for laparoscopic removal of a large retroperitoneal pelvic schwannoma attached to vital vessels: A case report 1.469
Feasibility and safety of total laparoscopic hysterectomy for uteri weighing from 1.5 kg to 11.000 kg 1.410
Editorial: Biological Mechanism-Based and Patient-Centered Management of Cancer-Related Symptoms and Syndromes 1.359
EFFICACY AND SAFETY OF A TWO DRUG-COMBINATION REGIMEN FOR CANCER-RELATED CACHEXIA IN THE CLINICAL PRACTICE 1.324
(0) Save to: more options IMPROVEMENT OF PHYSICAL ACTIVITY AS AN ALTERNATIVE OBJECTIVE VARIABLE TO MEASURE TREATMENT EFFECTS OF ANTI CACHEXIA THERAPY IN CANCER PATIENTS 1.213
Role of interleukin-2 (IL-2) in cancer-related immune deficiency: in vitro response to IL-2, production of IL-2, and IL-2 receptor expression in patients with advanced cancer 1.161
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 1.143
Quantitative evaluation of oxidative stress, chronic inflammatory indexes, and leptin in cancer patients: Correlation with stage and performance status. 1.058
Peripheral blood lymphocyte response to recombinant and non-recombinant interleukin 2 in previously treated patients with Hodgkin's disease, long-time off-therapy 1.000
null 998
New perspective on the nutritional approach to cancer-related anorexia/cachexia: Preliminary results of a randomised phase III clinical trial with five different arms of treatment 994
Interleukin 2 (IL 2) and cancer. In vitro response to exogenous R and non-R IL 2 by PHA-activated and non-PHA-activated PBMC from patients with cancer 955
Blocking inflammation to improve immunotherapy of advanced cancer 951
Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients 938
Laparoscopic management of a giant mucinous benign ovarian mass weighing 10150 grams: A case report 924
Interleukin 2 (IL 2) relationships with the cancer-related immunodeficiency: in vitro response to exogenous IL 2 by PHA-activated and non PHA-activated peripheral blood mononuclear cells from cancer patients 907
Cisplatin : an old drug with a newfound efficacy -- from mechanisms of action to cytotoxicity 868
The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications - a review 867
Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: A report of two cases 860
Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer 854
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress 835
Three cases of laparoscopic myomectomy performed during pregnancy for pedunculated uterine myomas 833
null 819
Successful pregnancy following myomectomy of a giant uterine myoma: role of a combined surgical approach 806
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters 802
Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report 781
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress 780
Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment 779
A PHASE II STUDY WITH ANTIOXIDANTS, BOTH IN THE DIET AND SUPPLEMENTED, PHARMACO-NUTRITIONAL SUPPORT,PROGESTAGEN AND ANTI-COX-2 SHOWING EFFICACY AND SAFETY IN PATIENTS WITH CANCER-RELATED ANOREXIA-CACHEXIA AND OXIDATIVE STRESS 778
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy 772
Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment 761
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer 750
Experimental drugs for chemotherapy-and cancer-related anemia 744
Antioxidant agents alpha lipoic acid, N-Acetyl cysteine and MESNA (2-mercaptoethane sulfonate) are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients 735
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer 732
null 709
Next-Generation Sequencing Whole-Genome Analysis for Targeted Treatment Approach of Metastatic Bartholin Gland Adenocarcinoma: An Emblematic Case Report and Review of the Literature 702
Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique 692
Novel technique of extracorporeal intrauterine morcellation after total laparoscopic hysterectomy: Three emblematic case reports 687
Laparoscopic management of isolated nodal recurrence in gynecological malignancies is safe and feasible even for large metastatic nodes up to 8 cm: A prospective case series 681
Improvement of physical activity as an alternative objective variable to measure treatment effects of anticachexia therapy in cancer patients 673
Randomised Phase III Clinical Trial of a Combined Treatment With Carnitine plus Celecoxib +/- Megestrol Acetate for Patients With Cancer-related Anorexia/cachexia Syndrome 654
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity 627
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy 624
Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites 622
Managing cancer-related anorexia/cachexia 613
Prognostic Role of Cell Blood Count in Chronic Myeloid Neoplasm and Acute Myeloid Leukemia and Its Possible Implications in Hematopoietic Stem Cell Transplantation 612
Cancer-related cachexia and oxidative stress: beyond current therapeutic options 608
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: An evaluation of effectiveness, safety and costs 606
The mechanism of cancer cell death by PARP inhibitors goes beyond DNA damage alone 589
Correlation of Leptin, Proinflammatory Cytokines and Oxidative Stress with Tumor Size and Disease Stage of Endometrioid (Type I) Endometrial Cancer and Review of the Underlying Mechanisms 588
Decrease in neutrophil-to-lymphocyte ratio during neoadjuvant chemotherapy as a predictive and prognostic marker in advanced ovarian cancer 587
The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression 583
Serum levels of leptin and proinflammatory cytokines in patients with advanced stage cancer at different sites 576
Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites 574
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment 573
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes 572
Cachexia as evidence of the mechanisms of resistance and tolerance during the evolution of cancer disease 570
Multitargeted treatment of cancer cachexia 561
Cachexia and oxidative stress in cancer: an innovative therapeutic management 559
A phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 555
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS): Interim results 554
Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report 553
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 553
Clinical and immunological evaluation of schizophyllan (SPG) in combination with standard chemotherapy in patients with head and neck squamous cell carcinoma 553
A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life 548
Antioxidant therapy for the treatment of oxidative stress associated to cancer and cancer-related anorexia/cachexia 541
Totale 114.698
Salva come PNG Salva come JPEG
Categoria #
all - tutte 218.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 218.800
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.019 0 0 0 0 0 0 0 0 0 1.621 1.487 911
2021/20227.039 551 514 450 439 721 447 469 481 605 537 702 1.123
2022/202313.188 1.054 1.398 1.168 1.001 925 1.437 747 1.423 965 978 1.353 739
2023/202415.777 994 639 532 1.061 1.520 2.821 2.198 1.004 749 1.070 1.661 1.528
2024/202519.801 2.461 3.737 3.090 3.232 1.625 2.406 1.441 195 420 384 400 410
2025/20269.388 593 534 1.406 998 745 650 1.876 429 870 1.287 0 0
Totale 147.394